(19)
(11) EP 1 263 785 A2

(12)

(88) Date of publication A3:
07.03.2002

(43) Date of publication:
11.12.2002 Bulletin 2002/50

(21) Application number: 00978539.5

(22) Date of filing: 10.11.2000
(51) International Patent Classification (IPC)7: C07K 14/54, A61K 38/20, G01N 33/574, A61P 33/00, A61P 35/00, A61P 37/00
(86) International application number:
PCT/US0031/044
(87) International publication number:
WO 0103/4645 (17.05.2001 Gazette 2001/20)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 11.11.1999 US 165236 P

(71) Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Rockville, MD 20852-3804 (US)

(72) Inventors:
  • PURI, Raj, K.
    Potomac, MD 20854 (US)
  • OSHIMA, Yasuo
    Rockville, MD 20852 (US)
  • JOSHI, Bharat, H.
    Rockville, MD 20892 (US)

(74) Representative: Smyth, Gyles Darren 
Marks & Clerk,57-60 Lincoln's Inn Fields
London WC2A 3LS
London WC2A 3LS (GB)

   


(54) MUTATED IL-13 MOLECULES AND THEIR USES